ETFsXtrackers USD Corporate Bond UCITS ETF 2D EUR Hedged
Xtrackers

Xtrackers USD Corporate Bond UCITS ETF 2D EUR Hedged

XDGE XETRADistributingIreland
Last close · EUR
9.76EUR
-0.20% · -€0.02
Published closes: 29 Oct 2026 - 30 Oct 2026
30 Oct 2026, close
XDGEBase
Fund charges
Not publishedFee basis unverified
Fund size
Not published
Return 1Y
-4.2%
Sharpe 3Y
0.07
Volatility 1Y
5.1%annualised
Holdings
3,402Fund holdings

Performance

Compare
  • XDGE-4.2%
  • Price, EUR

Returns

Returns1M3M6MYTD1Y3Y5Y
XDGE+2.0%-1.4%-2.8%-3.8%-4.2%+12.8%-14.4%
MSCI World+0.4%+4.9%+10.8%+16.0%+15.9%+75.5%+71.2%
Gap to MSCI World+1.6%-6.3%-13.6%-19.9%-20.1%-62.7%-85.6%

Risk and return

Sharpe ratio · 3Y
0.07
Below MSCI World · 1.24
Return p.a.
+3.1%
Volatility
7.1%
Max loss
-7.5%Apr 2025

Sharpe vs indices

MSCI World
1.24
S&P 500
1.21
STOXX Europe 600
1.04
MSCI Emerging Markets IMI
0.93
CAC 40
0.37
XDGE
0.07
Method

Weekly EUR returns from adjusted closes. Sharpe is the annualised excess return over the euro overnight rate (Xtrackers II EUR Overnight Rate Swap UCITS ETF 1C) divided by its volatility. Max loss uses daily closes.

Top holdings

Top 10
1.4%
Holdings
3,402
As of
Fund holdings
  1. 1ANHEUSER-BUSCH COMPANIES LLCUS03522AAJ970.18%
  2. 2CVS HEALTH CORPUS126650CZ110.16%
  3. 3T-MOBILE USA INCUS87264ABF120.16%
  4. 4SPACE EXPLORATION TECHNOLOGIES CORUS84615QAA130.15%
  5. 5META PLATFORMS INCUS30303MAH510.13%
  6. 6AMAZON.COM INCUS023135DF000.13%
  7. 7META PLATFORMS INCUS30303MAD480.13%
  8. 8SPACE EXPLORATION TECHNOLOGIES CORUS84615QAC780.13%
  9. 9SPACE EXPLORATION TECHNOLOGIES CORUS84615QAE350.13%
  10. 10META PLATFORMS INCUS30303MAK800.13%

Countries

Classified 100.0%
Largest
86.0%United States
Top 3
92.7%
Effective number
1.31 / HHI

Market cap

Weight vs holdings

1.4%of the fund sits in the top 10 holdings
  • Holdings 1-10
  • Holdings 11-50
  • Holdings 51-200
  • Holdings 201+

Size split

Not published

Compare ETFs in Copio.

ETF comparison in the Copio app, showing costs and returns with illustrative data.

Factual research, without a suitability score or investment recommendation. Past relationships can change.